LEVAQUIN (levofloxacin) solution. WARNING. Fluoroquinolones, including Levofloxacin, are associated with an increased risk of tendinitis and.
Fluoroquinolones, including Levofloxacin, may exacerbate muscle weakness in persons with myasthenia gravis. Avoid Levofloxacin in patients with a known history of myasthenia gravis.
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.
Table 3: Dosage Adjustment in Adult Patients with Renal Impairment (creatinine clearance < 50 mL/min) Dosage in Normal Renal Function Every 24 hours Creatinine Clearance 20 to 49 mL/min Creatinine Clearance 10 to 19 mL/min Hemodialysis or Chronic Ambulatory Peritoneal Dialysis (CAPD) 750 mg 750 mg every 48 hours 750 mg initial dose, then 500 mg every 48 hours 750 mg initial dose, then 500 mg every 48 hours 500 mg 500 mg initial dose, then 250 mg every 24 hours 500 mg initial dose, then 250 mg every 48 hours 500 mg initial dose, then 250 mg every 48 hours 250 mg No dosage adjustment required 250 mg every 48 hours.
Fluoroquinolones, including Levaquin, have been associated with disabling and potentially irreversible serious adverse reactions that have occurred together [see Warnings and Precautions (5.1)], including: Avoid Levaquin in patients with a known history of myasthenia gravis.
Levaquin is indicated for the treatment of complicated urinary tract infections due to Escherichia coli, Klebsiella pneumoniae, or Proteus mirabilis.
Because fluoroquinolones, including Levaquin, have been associated with serious adverse reactions and for some patients ABS is self-limiting, reserve Levaquin for treatment of ABS in patients who have no alternative treatment options.
Therapy with Levaquin may be initiated before results of these tests are known; once results become available, appropriate therapy should be selected.
Levofloxacin, sold under the trade names Levaquin among others, is an antibiotic. It is used to treat a number of bacterial infections including acute bacterial.
Levofloxacin is marketed by Sanofi-Aventis under a license agreement signed with Daiichi in 1993 under the trade name "Tavanic".
Package inserts mention that levofloxacin is to be avoided in patients with a known hypersensitivity to levofloxacin or other quinolone drugs.
Levofloxacin is a second-generation fluoroquinolone, being one of the isomers of ofloxacin, which was a broader-spectrum conformationally locked analog of norfloxacin ; both Ofloxacin and levofloxaxin were synthesized and developed by scientists at Daiichi Seiyaku.
Levaquin (levofloxacin) is a fluoroquinolone antibiotic that fights bacteria in the body. Levaquin is used to treat bacterial infections of the skin, sinuses, kidneys.
You should not use Levaquin if you are allergic to levofloxacin or other fluoroquinolones (ciprofloxacin, gemifloxacin, moxifloxacin, ofloxacin, norfloxacin, and others).
Levaquin (levofloxacin) is a fluoroquinolone antibiotic that fights bacteria in the body.
diabetes (especially if you use insulin or take oral diabetes medication);
a diuretic or "water pill"; theophylline;
Tendon and joint problems may be more likely in a child taking Levaquin. Do not give this medicine to a child without medical advice.
To make sure Levaquin is safe for you, l your doctor if you have:
You may not be able to use Levaquin if you have a muscle disorder.
Find a comprehensive guide to possible side effects including common and rare side effects when taking Levaquin (Levofloxacin) for.
Our Levaquin Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
oblong, white, imprinted with LEVAQUIN, 500.
Adverse reactions occurring in ≥ 1% of Levofloxacin-treated patients and less common adverse reactions, occurring in 0.1 to < 1% of Levofloxacin-treated patients, are shown in Table 4 and Table 5, respectively. The most common adverse drug reactions ( ≥ 3%) are nausea, headache, diarrhea, insomnia, constipation, and dizziness.
Because these reactions are reported voluntarily from a population of uncertain size, reliably estimating their frequency or establishing a causal relationship to drug exposure is not always possible.